ICON plc | Clinical Research Organisation (CRO) for Drug Development

Fortifying vaccines

Preparation and prevention against future infectious disease epidemics.

Sponsor and CRO pharmacovigilance and safety alliances

Outsourcing pharmacovigilance activities.

A guide to safety data migrations

Choosing the best approach to maintain data integrity.

Spotlight on regulatory reforms in China

Although China’s regulatory reforms have attracted many foreign companies to conduct trials in China, there are still challenges.

Featured Services

Seeking parallel consultation from regulators and HTA bodies in Europe

Market Access

Expertise in mission-critical pricing, market access, and reimbursement.�

Site & Patient Solutions

Transforming recruitment through patient-centric trials and real-world, real-time data.

Biotech

ICON provides full service outsourcing and flexible support for biotech specific needs such as due diligence and asset valuation.

Functional Resourcing

From recruitment of a single clinical professional to managing entire global functions.

Increasing Site and Patient Compliance

FIRECREST: Digital solutions to increase efficiency in clinical trials by driving site performance.

ICON Insights

30 March 2023

Mary O’Reilly reflects on International Women’s Day

In this blog, Mary O’Reilly reflects on the International Women’s Day panel and events held at ICON’s global headquarters in Dublin.

23 March 2023

How data science is changing the face of healthcare

In this podcast, Michael Goedde shares his journey in technology and his role in building the digital platform for healthcare systems at ICON.

16 March 2023

A positive step for diversity and inclusion in clinical trials – reflections on FDORA

Read this blog for updated recommendations and additional guidance on DCTs to ensure equitable access to cutting-edge therapeutics and clinical trials.

24 February 2023

Rare Disease Day diversity and inclusion

This event aims to raise awareness about the diversity of individuals affected by rare diseases. Find out how virtual events can be made more accessible and inclusive.

03 February 2023

My patient story - Margaritte De Falco

ICON's Margaritte De Falco shares her personal experience with ovarian cancer.

03 February 2023

My patient story - Claudia Egremont-Lee

ICON's Claudia Egremont-Lee shares her personal experience with breast cancer.

03 February 2023

My patient story - Chelsea Mason

ICON's Chelsea Mason shares her personal experiences with cancer.

18 January 2023

The importance of developing rTPP to build biotech asset value

Discover how Biotechs can build value into their asset by developing a reimbursable Target Product Profile (rTPP).

13 January 2023

The impact of real world evidence on drug marketing approval and reimbursement

Increasing use of real world data and real world evidence for market regulatory decisions can lead to a more holistic understanding of safety and potency factors for healthcare practices.

Services

Sectors

Therapeutics

Innovation

Insights

News & Events

About ICON

Healthcare Intelligence

Webinar: Rare disease week 2023 - Exploring accessibility in rare disease clinical research

Evidence Synthesis

Beyond buzzwords